-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B4g7ilcszmdCjEHuC9MXLA0sb9/MfxYqmzlYTQDDAY9fKLBjopknMAGIU+ihISIt guvQHBRWpVmXi6AixfGKjA== 0001082554-06-000036.txt : 20060407 0001082554-06-000036.hdr.sgml : 20060407 20060407203633 ACCESSION NUMBER: 0001082554-06-000036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060406 FILED AS OF DATE: 20060407 DATE AS OF CHANGE: 20060407 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAHON PAUL A CENTRAL INDEX KEY: 0001231589 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 06749395 BUSINESS ADDRESS: STREET 1: UNITED THERAPEUTIES CORP. STREET 2: 1110 SPRING STREET CITY: SILVERSPRING STATE: MD ZIP: 20910 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2006-04-06 0 0001082554 UNITED THERAPEUTICS CORP UTHR 0001231589 MAHON PAUL A 0 1 0 0 EVP & General Counsel Common Stock 2006-04-06 2006-04-06 4 M 0 2000 17.1 A 17000 D Common Stock 2006-04-06 2006-04-06 4 M 0 2500 13.17 A 19500 D Common Stock 2006-04-06 2006-04-06 4 S 0 2000 65.1135 D 17500 D Common Stock 2006-04-06 2006-04-06 4 S 0 2500 65.51 D 15000 D Employee Stock Options 17.1 2006-04-06 2006-04-06 4 M 0 2000 0 D 2003-01-02 2013-01-02 Common Stock 2000 327762 D Employee Stock Options 13.17 2006-04-06 2006-04-06 4 M 0 2500 0 D 2001-06-15 2011-06-15 Common Stock 2500 325262 D The exercise of stock options and the corresponding sale of 2,000 shares are pursuant to the 10b5-1 Plan adopted by the reporting person on March 12, 2004. The exercise of stock options and the corresponding sale of 2,500 shares are pursuant to the 10b5-1 Plan adopted by the reporting person on February 27, 2006. /s/ Paul A. Mahon 2006-04-07 -----END PRIVACY-ENHANCED MESSAGE-----